1 / 17

Evaluating Australia‘s National Strategy for Quality Use of Medicines

Evaluating Australia‘s National Strategy for Quality Use of Medicines. Results of indicator measurements 1992-2003. Quality Use of Medicines. National Strategy for Quality Use of Medicines established 1992. http://www.health.gov.au/nmp/quality.htm. Awareness . Enabling. Maintaining.

carminda
Télécharger la présentation

Evaluating Australia‘s National Strategy for Quality Use of Medicines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Evaluating Australia‘s National Strategy for Quality Use of Medicines Results of indicator measurements 1992-2003

  2. Quality Use of Medicines • National Strategy for Quality Use of Medicines established 1992 http://www.health.gov.au/nmp/quality.htm

  3. Awareness Enabling Maintaining Government Health professionals Partnership Industry Consumers The Vision Policy development Facilitation and co-ordination Objective information and ethical promotion HealthyConsumers Education & training Services and interventions Routine data collection

  4. The Original Vision for QUM (1992) National Facilitation & Co-ordination Australian National Formulary Consumer education for self-reliance Awareness Motivation Confidence Stimulate teamwork General awareness Objective Information Education & Training Consumer Services Provider Services Campaigns School kits & adult learning Academic detailing National Therapeutic Guidelines Medication records Elderly Core curricula for providers Models of practice Asthma Medication review Australian Prescriber Analgesics Undergraduate, postgraduate & continuing ed’n Audit & feedback Compliance aids Consumer Medicines Information Out-of-date medication Disposal of unwanted medicines Critical appraisal of promotion Multidisciplinary team approach Ethical promotion Targeted Grants for Further Development

  5. Evaluation Indicators were developed in1993 • to mirror the national strategy framework • address all key strategies, all partners, all stages of learning • monitor process, impact and outcome (implementation and effect) http://www.health.gov.au/nmp/publications/pharm.htm

  6. Process Indicator: Are there nationally recognised therapeutic guidelines? • Therapeutic guidelinesnow cover ten therapeutic areas • 60% general practitionersreport using antibiotic guidelines http://www.tg.com.au/home/index.html

  7. Process Indicator: Is there Consumer Medicines Information? • Consumer medicines information developed • for over 1900 products • 60% of consumers report receiving consumer medicines information with their last new medicine • http://www.health.gov.au/nmp/pdf/cmi.pdf

  8. Process Indicator: Are medication review services available? • 1998: services for aged care facilities • 127,000 (85%) residents in Australia provided with the service in 2002 • 2001: funding for community services • 1294 (~10%) pharmacists accredited, • 3272 (~65%) pharmacies registered to provide the service • 22,000 home visits in 2003 • http://www.hic.gov.au/providers/incentives_allowances/pharmacy_agreement/about_hmr.htm

  9. Process Indicator: Are there guidelines for medication management in aged-care facilities? • Guidelines for medication management in aged care facilities • 3rd edition 2003 • ~40,000 distributed • http://www.health.gov.au/nmp/pdf/resguide.pdf

  10. Process Indicator: Is there a medication disposal service? • Return Unwanted Medicines, established 1998 • 250 tonnes of medication collected in 2003 http://www.returnmed.com.au

  11. Process Indicator: Is there Quality Use of Medicines education for health professionals? • National Prescribing Service • Newsletters & prescribing feedback • over 20,000 GPs • Locally based-facilitators • Academic detailing, • Clinical audits, • Case studies, • over 50% of GPs participating • http://www.nps.org.au/

  12. Impact indicators: Percent of consumers asking questions of their doctor when prescribed a new medicine

  13. Impact indicator: changes in medication use Ratio of inhaled corticosteroids to short acting bronchodilators for asthma

  14. Outcome indicators: changes in hospitalisation rates Hospitalisation rates for asthma

  15. Where are we up to?

  16. Information technology Complementary Health Care Private health industry Other health policies Media • National Health Policy • National Medicines Policy • Federal, State & Territory QUM Policies • Integrated & consistent Awareness Enabling Maintaining Medication Review funds • Co-ordination, facilitation mechanism • Funding & evaluation process • Dialogue & collaboration • All involved & endorsed • Therapeutic Guidelines • National Therapeutics Bulletin • National Formulary • CMI • Codes of Conduct HealthyConsumers National Prescribing Service Partnership • QUM Curricula ( all groups) • ADR reporting (HP’s & consumers) • Medication management aids (funded) • Discharge planning standards • Medication review services • Medication disposal services • Drug utilisation feed back • Campaigns • National Media Liaison Strategy • Drug use audits • National Data set

  17. Lessons learned • Useful for identifying successes and gaps in implementation & informing strategic action plans • Articulation of essential activities in the policy document & in manual of indicators has led to prioritisation • Continuous feedback through a number of different channels and in a number of different formats has been essential

More Related